TAK Form 144: Planned Insider Sale of 40.9k ADSs on 07-Jul-25

Rhea-AI Filing Summary

Takeda Pharmaceutical Company Limited (TAK) has filed a Form 144 indicating the proposed sale of 40,919 American Depositary Shares (ADSs) through Interactive Brokers on or about 07 July 2025. The aggregate market value of the planned sale is US$630,970.98, representing approximately 0.03 % of the company’s 123,490,548 ADSs outstanding. The shares derive from restricted stock unit (RSU) awards that vested on 01 July 2025 and are being sold for the account of an unnamed insider. No other sales have been reported by this person in the past three months, and the filer affirms there is no undisclosed material adverse information regarding the issuer.

The filing is procedural and signals an intent—not a completed transaction—allowing the insider to sell restricted or control securities under Rule 144. Given the limited size relative to Takeda’s float and market capitalization, the disclosure is generally viewed as immaterial to the company’s fundamental outlook.

Insights

Securities Analyst

TL;DR Minor insider Form 144 for ~US$631k TAK ADSs; negligible impact on valuation.

The notice covers 40,919 ADSs (0.03 % of outstanding) sourced from recently vested RSUs. No prior three-month sales are disclosed. Form 144 filings are routine compliance steps and do not guarantee execution. The modest size and absence of other negative signals suggest no material effect on liquidity, ownership concentration, or investor sentiment. I therefore view the news as informational only, with neutral impact.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
American Depositary Shares (ADSs)	Interactive Brokers LLC One Pickwick Plaza Greenwich CT 06830	40919	630970.98	123490548	07/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ADSs	07/01/2025	Restricted Stock Unit Awards - Vested.	Takeda Pharmaceutical Company Limited			87852	07/01/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Takeda (TAK) file with the SEC?

Takeda filed a Form 144 disclosing a proposed sale of restricted ADSs under Rule 144.

How many Takeda ADSs are proposed for sale?

The filing covers 40,919 ADSs.

What is the aggregate market value of the shares?

The shares have an aggregate market value of US$630,970.98.

When is the approximate sale date for the ADSs?

The filer indicates an approximate sale date of 07 July 2025.

How significant is this sale relative to Takeda’s total ADSs outstanding?

The proposed sale represents roughly 0.03 % of the 123,490,548 ADSs outstanding.

Where will the ADSs be sold?

The securities are expected to be sold on the NYSE through Interactive Brokers LLC.